FMC Corp. stock drops following weak guidance and analyst downgrades
Shares of FMC Corp . (NYSE: NYSE:FMC) tumbled 32% as the market responded to the company's disappointing forward-looking statements and a slew of analyst downgrades. Despite surpassing Q4 earnings per ...
Bristol-Myers Squibb Stock Falls on Surprisingly Weak Guidance
Shares in Bristol-Myers Squibb fell more than 4% in premarket trading Thursday, after the drug maker gave 2025 guidance that undershot analyst expectations. Bristol expects sales of about $45.5 ...